Terms: = Breast cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Staging
4 results:
1. Effects of MFG-E8 expression on the biological characteristics of ovarian cancer cells via the AKT/mtor/S6K signalling pathway.
Li N; Wang Y; Liu L; Wang P; Wu X
J Obstet Gynaecol; 2023 Dec; 43(1):2151354. PubMed ID: 36484512
[TBL] [Abstract] [Full Text] [Related]
2. A novel epigenetic signature for overall survival prediction in patients with breast cancer.
Bao X; Anastasov N; Wang Y; Rosemann M
J Transl Med; 2019 Nov; 17(1):380. PubMed ID: 31747912
[TBL] [Abstract] [Full Text] [Related]
3. RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic breast cancer Patients.
Keup C; Mach P; Aktas B; Tewes M; Kolberg HC; Hauch S; Sprenger-Haussels M; Kimmig R; Kasimir-Bauer S
Clin Chem; 2018 Jul; 64(7):1054-1062. PubMed ID: 29769179
[TBL] [Abstract] [Full Text] [Related]
4. 18F-FDG PET/CT in the staging and Management of breast cancer: Value in Disease Outcome and Planning Therapy.
Garcia JR; Pérez C; Bassa P; Capdevila L; Ramos F; Valenti V
Clin Nucl Med; 2017 Mar; 42(3):191-192. PubMed ID: 28045731
[TBL] [Abstract] [Full Text] [Related]
